Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2015 Sep 30;289(2):213–222. doi: 10.1016/j.taap.2015.09.022

Figure 4. No JNK activation or mitochondrial translocation after AMAP in PHH.

Figure 4

JNK activation in the cytosol (A) and P-JNK translocation to the mitochondria (B) were evaluated by western blotting. Mitochondrial fraction from APAP-treated PHH was used as positive control. (C) Densitometry of cytosolic JNK activation. Data represent mean ± SE from densitometry using cells from 3 donors.